Who are IV Antibacterial Agents's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Orally antibacterial agents.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/iv-antibacterial-agents.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

IV Antibacterial Agents — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IV Antibacterial Agents (IV Antibacterial Agents) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Antibacterial agent (broad category). Area: Infectious Disease.

marketed Antibacterial agent (broad category) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

IV Antibacterial Agents (IV Antibacterial Agents) — Assistance Publique - Hôpitaux de Paris. IV antibacterial agents kill or inhibit the growth of bacteria through various mechanisms including cell wall disruption, protein synthesis inhibition, or DNA damage.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
IV Antibacterial Agents TARGET	IV Antibacterial Agents	Assistance Publique - Hôpitaux de Paris	marketed	Antibacterial agent (broad category)
Orally antibacterial agents	Orally antibacterial agents	Assistance Publique - Hôpitaux de Paris	marketed	Antibacterial agent (broad category)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Antibacterial agent (broad category) class)

Assistance Publique - Hôpitaux de Paris · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). IV Antibacterial Agents — Competitive Intelligence Brief. https://druglandscape.com/ci/iv-antibacterial-agents. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab